The central nervous system’s proteogenomic and spatial imprint upon systemic viral infections with SARS-CoV-2
Author:
Radke Josefine, Meinhardt Jenny, Aschman Tom, Chua Robert Lorenz, Farztdinov Vadim, Lukkassen Sören, Ten Foo Wei, Friebel Ekaterina, Ishaque Naveed, Franz Jonas, Huhle Valerie Helena, Mothes Ronja, Peters Kristin, Thomas Carolina, Streit Simon, Manitius Regina von, Körtvélyessy Péter, Vielhaber Stefan, Reinhold Dirk, Hauser Anja, Osterloh Anja, Enghard Philipp, Ihlow Jana, Elezkurtaj Sefer, Horst David, Kurth Florian, Müller Marcel A., Gassen Nils C., Schneider Julia, Jechow Katharina, Timmermann Bernd, Fernandez-Zapata Camila, Böttcher Chotima, Stenzel Werner, Wyler Emanuel, Corman Victor, Stadelmann-Nessler Christine, Ralser Markus, Eils Roland, Heppner Frank L., Mülleder Michael, Conrad Christian, Radbruch HelenaORCID
Abstract
AbstractIn COVID-19 neurological alterations are noticed during the systemic viral infection. Various pathophysiological mechanisms on the central nervous system (CNS) have been suggested in the past two years, including the viral neurotropism hypothesis. Nevertheless, neurological complications can also occur independent of neurotropism and at different stages of the disease and may be persistent.Previous autopsy studies of the CNS from patients with severe COVID-19 show infiltration of macrophages and T lymphocytes, especially in the perivascular regions as well as pronounced microglial activation, but without signs of viral encephalitis.However, there is an ongoing debate about long-term changes and cytotoxic effects in the CNS due to the systemic inflammation.Here, we show the brain-specific host response during and after COVID-19. We profile single-nucleus transcriptomes and proteomes of brainstem tissue from deceased COVID-19 patients who underwent rapid autopsy. We detect a disease phase-dependent inflammatory type-I interferon response in acute COVID-19 cases. Integrating single-nucleus RNA sequencing and spatial transcriptomics, we could localize two patterns of reaction to severe systemic inflammation. One neuronal with direct focus on cranial nerve nuclei and one diffusely affecting the whole brainstem, the latter reflecting a bystander effect that spreads throughout the vascular unit and alters the transcriptional state of oligodendrocytes, microglia and astrocytes.Our results indicate that even without persistence of SARS-CoV-2 in the CNS, the tissue activates highly protective mechanisms, which also cause functional disturbances that may explain the neurological symptoms of COVID-19, triggered by strong systemic type-I IFN signatures in the periphery.
Publisher
Cold Spring Harbor Laboratory
Reference148 articles.
1. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China;JAMA Neurol,2020 2. Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis;Curr Opin Neurol,2021 3. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry;Neurology,2020 4. Lou, J.J. , et al. Neuropathology of COVID-19 (neuro-COVID): clinicopathological update. Free Neuropathol 2(2021). 5. “Neurological manifestations of COVID-19” - guideline of the German society of neurology;Neurol Res Pract,2020
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|